Sugi Predict

Sugi Predict / Compounds / SCHEMBL92299

SCHEMBL92299

SCHEMBL92299

COc1ccc(-c2ccc3c(c2)C(C)(C)c2cc(-c4ccc5c(c4)-c4cccnc4C5(C)C)ccc2-3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 2/20 0.44
▸ DYRK1A Q13627 2/20 0.42
▸ CLK4 Q9HAZ1 1/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ SYK P43405 5/20 0.37
▸ CCNB2 O95067 1/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ CCNB1 P14635 1/20 0.36
▸ RIPK1 Q13546 1/20 0.36
▸ CCNB3 Q8WWL7 1/20 0.36
▸ IDH1 O75874 1/20 0.36
▸ AURKB Q96GD4 1/20 0.35
▸ INCENP Q9NQS7 1/20 0.35
▸ ABL1 P00519 2/20 0.35
▸ ABCB1 P08183 2/20 0.35
▸ BCR P11274 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL81677 0.88 PDK2 (0.42) PDK2NPC1RAB9AALDH1A1SYK
SCHEMBL12393754 0.80 PDK2 (0.63) PDK2NPC1RAB9AABL1ABCB1
SCHEMBL13385079 0.80 PDK2 (0.63) PDK2NPC1RAB9AABL1ABCB1
SCHEMBL81678 0.77 PDK2 (0.40) PDK2NPC1RAB9AKDM4EALDH1A1
SCHEMBL12393752 0.76 PDK2 (0.57) PDK2NPC1RAB9AKDM4EALDH1A1
SCHEMBL12393750 0.76 PDK2 (0.57) PDK2NPC1RAB9AKDM4EALDH1A1
SCHEMBL12865697 0.76 PDK2 (0.58) PDK2NPC1RAB9AKDM4EABL1
SCHEMBL10025101 0.75 PDK2 (0.47) PDK2DYRK1ANPC1RAB9AKDM4E
SCHEMBL10153624 0.74 PDK2 (0.55) PDK2NPC1RAB9AKDM4EALDH1A1
SCHEMBL81614 0.73 PDK2 (0.41) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129899-B1 Azafluorene derivative and organic light-emitting device using the derivative CANON KABUSHIKI KAISHA (JP) 2012-03-06 — — US disclosed
US-20120049176-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2012-03-01 — — US disclosed
US-8110685-B2 Efficient, durable electron transport layers; low driving voltage; simple, low cost production CANON KABUSHIKI KAISHA (JP) 2012-02-07 — — US disclosed
US-8110685-B2 Efficient, durable electron transport layers; low driving voltage; simple, low cost production CANON KABUSHIKI KAISHA (JP) 2012-02-07 — — US disclosed
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2008-06-26 — — US disclosed
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2008-06-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE AZI2, CYP1A2, CYP2C19 PDK2 663/4885DYRK1A 2989/4885CLK4 3773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.